Security
Emergent Biosolutions, Inc. · EBS
EBSNYSECommon stockCurrentCIK 1367644Updated Oct 4, 2026
EBS price & chart
Loading TradingView…
NYSE:EBS on TradingView ↗About the company
Joseph Papa President and Chief Executive Officer Richard Lindahl EVP, Chief Financial Officer and Treasurer Jessica Perl SVP, General Counsel and Corporate Secretary Paul Williams SVP, Products Business Coleen Glessner EVP, Quality, Ethics and Compliance Simon Lowry, M.D. Chief Medical Officer, Head of Research and Development Stephanie Duatschek SVP, Chief Strategy and Transformation Officer Michelle Pepin SVP, Chief Human Resources Officer Bill Hartzel SVP, Manufacturing and Bioservices Emergent’s Executive Management Team
In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS ↗
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
Other Events
Items 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Costs Associated with Exit or Disposal Activities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 2.02, 2.05, 5.02, 7.01, 9.01
SCHEDULE 13G/A - filed by VANGUARD CAPITAL MANAGEMENT LLC regarding Emergent BioSolutions Inc.
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,318,600,000Source | 1,389,700,000Source | 1,823,200,000Source | 3,166,300,000Source |
| Property, Plant and Equipment, NetUSD | 205,400,000Source | 270,600,000Source | 382,800,000Source | 817,600,000Source |
| GoodwillUSD | 0Source | 0Source | 0Source | 218,200,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 436,500,000Source | 501,500,000Source | 566,600,000Source | 728,800,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 205,400,000Source | 99,500,000Source | 111,700,000Source | 642,600,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 84,200,000Source | 154,500,000Source | 191,000,000Source | 159,200,000Source |
| Inventory, NetUSD | 343,400,000Source | 311,700,000Source | 328,900,000Source | 350,700,000Source |
| Assets, CurrentUSD | 662,500,000Source | 598,700,000Source | 679,500,000Source | 1,210,400,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 25,800,000Source | 26,900,000Source | 47,900,000Source | 57,900,000Source |
| Operating Lease, Right-of-Use AssetUSD | 10,600,000Source | 11,700,000Source | 16,200,000Source | 19,400,000Source |
| Other Assets, NoncurrentUSD | 14,200,000Source | 18,900,000Source | 194,300,000Source | 191,300,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 796,000,000Source | 906,900,000Source | 1,173,900,000Source | 1,778,600,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 100,000Source | 100,000Source | 100,000Source | 100,000Source |
| Additional Paid in CapitalUSD | 942,400,000Source | 928,000,000Source | 904,400,000Source | 873,500,000Source |
| Retained Earnings (Accumulated Deficit)USD | -159,800,000Source | -212,400,000Source | -21,800,000Source | 738,700,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -7,500,000Source | -5,200,000Source | -5,700,000Source | 3,100,000Source |
| Stockholders' Equity Attributable to ParentUSD | 522,600,000Source | 482,800,000Source | 649,300,000Source | 1,387,700,000Source |
| Liabilities and EquityUSD | 1,318,600,000Source | 1,389,700,000Source | 1,823,200,000Source | 3,166,300,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 132,200,000Source | 162,400,000Source | 651,300,000Source | 1,228,900,000Source |
| Operating Lease, Liability, CurrentUSD | 2,400,000Source | 2,700,000Source | 3,500,000Source | 5,800,000Source |
| Accounts Payable, CurrentUSD | 55,600,000Source | 60,900,000Source | 112,200,000Source | 103,500,000Source |
| Operating Lease, Liability, NoncurrentUSD | 9,200,000Source | 9,700,000Source | 13,800,000Source | 14,800,000Source |
| Deferred Income Tax Liabilities, NetUSD | 37,800,000Source | 41,700,000Source | 47,200,000Source | 59,700,000Source |
| Other Liabilities, NoncurrentUSD | 53,900,000Source | 39,100,000Source | 28,900,000Source | 41,500,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 12,200,000Source | 17,700,000Source | 18,600,000Source | 34,900,000Source |
| Deferred Tax Liabilities, NetUSD | 37,800,000Source | 41,700,000Source | 47,200,000Source | 59,700,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | — | 0Source | 413,700,000Source | 957,300,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 572,100,000Source | 663,700,000Source | 446,500,000Source | 448,500,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 95,800,000Source | 108,800,000Source | 125,100,000Source | 143,300,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 16,200,000Source | 18,000,000Source | 23,100,000Source | 45,100,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -25,500,000Source | 24,400,000Source | 21,600,000Source | -118,100,000Source |
| Increase (Decrease) in InventoriesUSD | 30,300,000Source | 24,500,000Source | -600,000Source | 57,100,000Source |
| Increase (Decrease) in Accounts PayableUSD | -8,400,000Source | -33,000,000Source | 10,600,000Source | -14,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | -3,900,000Source | -5,500,000Source | -7,300,000Source | -33,700,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 170,600,000Source | 58,700,000Source | -206,300,000Source | -34,100,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 69,400,000Source | 125,200,000Source | 212,300,000Source | -381,300,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 13,800,000Source | 22,900,000Source | 51,600,000Source | 115,800,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 1,400,000Source | 1,200,000Source | 2,500,000Source | 5,900,000Source |
| Payments for Repurchase of Common StockUSD | 24,900,000Source | 0Source | 0Source | 82,100,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -136,600,000Source | -190,000,000Source | -535,700,000Source | 481,200,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 103,500,000Source | -6,100,000Source | -530,900,000Source | 66,300,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 209,100,000Source | 105,600,000Source | 111,700,000Source | 642,600,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 49,700,000Source | 64,000,000Source | 68,300,000Source | 33,000,000Source |
| Income Taxes Paid, NetUSD | 40,000,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 100,000Source | 0Source | -1,200,000Source | 500,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 16,200,000Source | 18,000,000Source | 23,100,000Source | 45,100,000Source |
| Amortization of Debt Issuance CostsUSD | 9,800,000Source | 7,400,000Source | 21,300,000Source | 4,100,000Source |
| Amortization of Intangible AssetsUSD | 65,100,000Source | 65,100,000Source | 65,600,000Source | 59,900,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | 0Source | 400,000Source |
| DepreciationUSD | 30,700,000Source | 43,700,000Source | 59,500,000Source | 83,400,000Source |
| Gain (Loss) on Disposition of AssetsUSD | -4,500,000Source | -28,700,000Source | — | — |
| Gain (Loss) on Disposition of BusinessUSD | 0Source | 24,300,000Source | 74,200,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | -12,200,000Source | 600,000Source | 2,500,000Source | — |
| GoodwillUSD | 0Source | 0Source | 0Source | 218,200,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 218,200,000Source | 6,700,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | 6,700,000Source |
| Income Tax Expense (Benefit)USD | 30,200,000Source | 47,700,000Source | 29,300,000Source | -7,400,000Source |
| InterestExpenseNonoperatingUSD | 59,300,000Source | 71,000,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 52,600,000Source | -190,600,000Source | -760,500,000Source | -211,600,000Source |
| Nonoperating Income (Expense)USD | -17,300,000Source | -34,200,000Source | -4,800,000Source | -49,000,000Source |
| Operating Costs and ExpensesUSD | 642,800,000Source | 1,152,300,000Source | 1,775,700,000Source | 1,287,500,000Source |
| Other Nonoperating Income (Expense)USD | 54,200,000Source | 12,500,000Source | 8,900,000Source | -11,700,000Source |
| Pension Cost (Reversal of Cost)USD | 0Source | 0Source | 600,000Source | 800,000Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 0Source | 8,400,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | 0Source | 500,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 742,900,000Source | 1,043,600,000Source | 1,049,300,000Source | — |
| Cost of RevenueUSD | 326,200,000Source | — | 705,400,000Source | 693,100,000Source |
| Selling, General and Administrative ExpenseUSD | 186,100,000Source | 308,000,000Source | 368,400,000Source | 339,500,000Source |
| Operating Income (Loss)USD | 100,100,000Source | -108,700,000Source | -726,400,000Source | -170,000,000Source |
| Other Nonoperating Income (Expense)USD | 54,200,000Source | 12,500,000Source | 8,900,000Source | -11,700,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 82,800,000Source | -142,900,000Source | -731,200,000Source | -219,000,000Source |
| Income Tax Expense (Benefit)USD | 30,200,000Source | 47,700,000Source | 29,300,000Source | -7,400,000Source |
| Net Income (Loss) Attributable to ParentUSD | 52,600,000Source | -190,600,000Source | -760,500,000Source | -211,600,000Source |
| Earnings Per Share, BasicUSD per share | 0.98Source | -3.6Source | -14.85Source | -4.22Source |
| Earnings Per Share, DilutedUSD per share | 0.93Source | -3.6Source | -14.85Source | -4.22Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 53,500,000Source | 53,000,000Source | 51,200,000Source | 50,100,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 56,700,000Source | 53,000,000Source | 51,200,000Source | 50,100,000Source |
| Interest Expense (non-operating)USD | 59,300,000Source | 71,000,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 65,100,000Source | 65,100,000Source | 65,600,000Source | 59,900,000Source |
| Current Income Tax Expense (Benefit)USD | 34,100,000Source | 53,200,000Source | 36,600,000Source | 26,300,000Source |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to SettlementUSD | — | — | 0Source | 400,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 218,200,000Source | 6,700,000Source |
| Gross ProfitUSD | — | — | 317,600,000Source | 383,000,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | 82,800,000Source | -142,900,000Source | -731,200,000Source | -218,600,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -4,700,000Source | -355,500,000Source | -805,100,000Source | -442,600,000Source |
| Interest ExpenseUSD | — | — | 87,900,000Source | 37,300,000Source |
| Nonoperating Income (Expense)USD | -17,300,000Source | -34,200,000Source | -4,800,000Source | -49,000,000Source |
| Operating Costs and ExpensesUSD | 642,800,000Source | 1,152,300,000Source | 1,775,700,000Source | 1,287,500,000Source |
| Research and Development ExpenseUSD | 53,200,000Source | 70,700,000Source | 111,400,000Source | 188,300,000Source |
Filing attachments
d921176dex991.htm · 8-K · 2026-01-14
EX-99.1 2 d921176dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Combating Public Health Threats for Communities Around the World th 44 Annual J.P. Morgan Healthcare Conference Joe Papa President and Chief Executive Officer January 14, 2026 1 1 Safe Harbor Statement/Trademarks This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements, other than statements of historical fact, including statements reg…
Read attachment ↗d916387dex991.htm · 8-K · 2025-01-15
EX-99.1 2 d916387dex991.htm EX-99.1 EX-99.1 January 15, 2025 43rd Annual J.P. Morgan Healthcare Conference Joe Papa President & CEO Exhibit 99.1 This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including statements regarding the future performance of the Company or any of our businesses, our business strategy, future operations, future financial positio…
Read attachment ↗